肠肝轴的现代概念及其在肝脏疾病中的作用

被引：90

作者：

王全楚

步子恒

李青上

机构：

[1] 解放军第中心医院感染科

来源：

胃肠病学和肝病学杂志 | 2015年 / 24卷 / 09期

关键词：

肠肝轴; 非酒精性脂肪肝; 酒精性脂肪肝; 肝硬化; 肝细胞癌;

D O I：

暂无

中图分类号：

R575.5 [肝代谢障碍];

学科分类号：

100201 [内科学];

摘要：

目前研究发现肝脏疾病与肠道有着密切的关系。在引起肝脏疾病发病的众多因素之中,肠道菌群起着重要作用,它能诱导脂肪变性、炎症及肝纤维化。本文探讨了肠肝轴与肝脏疾病的关系,通过总结目前最新的证据,从肝肠轴的角度为临床寻找一些可能的治疗策略。

引用

页码：1155 / 1158

页数：4

共 15 条

[1]

Gut microbiota in alcoholic liver disease: Pathogenetic role and therapeutic perspectives [J].

Malaguarnera, Giulia ;

Giordano, Maria ;

Nunnari, Giuseppe ;

Bertino, Gaetano ;

Malaguarnera, Michele .

WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (44) :16639-16648

[2]

Effects of probiotic therapy on hepatic encephalopathy in patients with liver cirrhosis:an updated meta-analysis of six randomized controlled trials.[J].Jun Xu;Rui Ma;Li-Feng Chen;Li-Jun Zhao;Kan Chen;Ren-Bing Zhang;.Hepatobiliary & Pancreatic Diseases International.2014, 04

[3]

Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease [J].

Miura, Kouichi ;

Ohnishi, Hirohide .

WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (23) :7381-7391

[4]

3,3′-Diindolylmethane attenuates LPS-mediated acute liver failure by regulating miRNAs to target IRAK4 and suppress Toll-like receptor signalling [J].

Tomar, S. ;

Nagarkatti, M. ;

Nagarkatti, P. S. .

BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (08) :2133-2147

[5]

Toll-like Receptor 5 in Obesity: The Role of Gut Microbiota and Adipose Tissue Inflammation [J].

Pekkala, Satu ;

Munukka, Eveliina ;

Kong, Lingjia ;

Pollanen, Eija ;

Autio, Reija ;

Roos, Christophe ;

Wiklund, Petri ;

Fischer-Posovszky, Pamela ;

Wabitsch, Martin ;

Alen, Markku ;

Huovinen, Pentti ;

Cheng, Sulin .

OBESITY, 2015, 23 (03) :581-590

[6]

Protective effect of Bifidobacterium pseudocatenulatum CECT7765 against induced bacterial antigen translocation in experimental cirrhosis [J].

Moratalla, Alba ;

Gomez-Hurtado, Isabel ;

Santacruz, Arlette ;

Moya, Angela ;

Peiro, Gloria ;

Zapater, Pedro ;

Gonzalez-Navajas, Jose M. ;

Gimenez, Paula ;

Such, Jose ;

Sanz, Yolanda ;

Frances, Ruben .

LIVER INTERNATIONAL, 2014, 34 (06) :850-858

[7]

Can non-selective beta-blockers prevent hepatocellular carcinoma in patients with cirrhosis? [J].

Thiele, Maja ;

Wiest, Reiner ;

Gluud, Lise Lotte ;

Albillos, Agustin ;

Krag, Aleksander .

MEDICAL HYPOTHESES, 2013, 81 (05) :871-874

[8]

Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis [J].

Vlachogiannakos, Jiannis ;

Viazis, Nikos ;

Vasianopoulou, Panagiota ;

Vafiadis, Irene ;

Karamanolis, Dimitrios G. ;

Ladas, Spiros D. .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (03) :450-455

[9]

Regulation of T Helper 17 by Bacteria: An Approach for the Treatment of Hepatocellular Carcinoma.[J].Cecilia Ying Ju Sung;Nikki Pui-yue Lee;Hani El-Nezami;Weiliang Xia.International Journal of Hepatology.2012,

[10]

Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis: a double-blind placebo-controlled randomized-controlled trial [J].

Pande, Chandana ;

Kumar, Ashish ;

Sarin, Shiv Kumar .

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 24 (07) :831-839

← 1 2 →